These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 19962256)

  • 1. Liver disease in older women.
    Frith J; Newton JL
    Maturitas; 2010 Mar; 65(3):210-4. PubMed ID: 19962256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic liver disease in an ageing population.
    Frith J; Jones D; Newton JL
    Age Ageing; 2009 Jan; 38(1):11-8. PubMed ID: 19029099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D and parathyroid hormone in outpatients with noncholestatic chronic liver disease.
    Fisher L; Fisher A
    Clin Gastroenterol Hepatol; 2007 Apr; 5(4):513-20. PubMed ID: 17222588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epidemiology of newly diagnosed chronic liver disease in gastroenterology practices in the United States: results from population-based surveillance.
    Bell BP; Manos MM; Zaman A; Terrault N; Thomas A; Navarro VJ; Dhotre KB; Murphy RC; Van Ness GR; Stabach N; Robert ME; Bower WA; Bialek SR; Sofair AN
    Am J Gastroenterol; 2008 Nov; 103(11):2727-36; quiz 2737. PubMed ID: 18684170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etiologies of chronic liver diseases in Hong Kong.
    Fung KT; Fung J; Lai CL; Yuen MF
    Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):659-64. PubMed ID: 17625435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic liver disease in central Harlem: the role of alcohol and viral hepatitis.
    Frieden TR; Ozick L; McCord C; Nainan OV; Workman S; Comer G; Lee TP; Byun KS; Patel D; Henning KJ
    Hepatology; 1999 Mar; 29(3):883-8. PubMed ID: 10051493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for hepatitis A and B antibodies in patients with chronic liver disease.
    Lau DT; Hewlett AT
    Am J Med; 2005 Oct; 118 Suppl 10A():28S-33S. PubMed ID: 16271538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of chronic liver disease on bone mineral density and bone metabolism markers in postmenopausal women.
    Uretmen S; Gol M; Cimrin D; Irmak E
    Eur J Obstet Gynecol Reprod Biol; 2005 Nov; 123(1):67-71. PubMed ID: 16051419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term liver dysfunction after allogeneic bone marrow transplantation: clinical features and course in 61 patients.
    Tomás JF; Pinilla I; García-Buey ML; García A; Figuera A; Gómez-García de Soria VGG ; Moreno R; Fernández-Rañada JM
    Bone Marrow Transplant; 2000 Sep; 26(6):649-55. PubMed ID: 11035372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of GB virus-C/hepatitis G virus infection in patients with cryptogenic chronic liver disease and in patients with primary biliary cirrhosis or Wilson's disease.
    Tagger A; Ribero ML; Larghi A; Donato F; Zuin M; Chiesa R; Benetti G; Ramella G; Borzio M; Podda M
    Am J Gastroenterol; 1999 Feb; 94(2):484-8. PubMed ID: 10022651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of health-related quality of life in patients with chronic liver disease.
    Afendy A; Kallman JB; Stepanova M; Younoszai Z; Aquino RD; Bianchi G; Marchesini G; Younossi ZM
    Aliment Pharmacol Ther; 2009 Sep; 30(5):469-76. PubMed ID: 19508612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The RANKL/OPG system and bone mineral density in patients with chronic liver disease.
    Moschen AR; Kaser A; Stadlmann S; Millonig G; Kaser S; Mühllechner P; Habior A; Graziadei I; Vogel W; Tilg H
    J Hepatol; 2005 Dec; 43(6):973-83. PubMed ID: 16143421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of diabetes on the severity of liver disease.
    Hickman IJ; Macdonald GA
    Am J Med; 2007 Oct; 120(10):829-34. PubMed ID: 17904449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The value of serum retinol-binding protein 4 levels for determining disease severity in patients with chronic liver disease].
    Kwon JH; Park ST; Kim GD; You CR; Kim JD; Woo HY; Jang JW; Kim CW; Bae SH; Choi JY; Yoon SK
    Korean J Hepatol; 2009 Mar; 15(1):59-69. PubMed ID: 19346786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society.
    Menopause; 2010; 17(1):25-54; quiz 55-6. PubMed ID: 20061894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The epidemiology of nonalcoholic fatty liver disease in adults.
    Clark JM
    J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S5-10. PubMed ID: 16540768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroepidemiology of hepatitis A in patients with chronic liver disease.
    Saab S; Lee C; Shpaner A; Ibrahim AB
    J Viral Hepat; 2005 Jan; 12(1):101-5. PubMed ID: 15655056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [CBO guideline 'Osteoporosis' (second revision].
    Pols HA; Wittenberg J
    Ned Tijdschr Geneeskd; 2002 Jul; 146(29):1359-63. PubMed ID: 12162173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
    Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
    Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.